4//SEC Filing
Kaufmann Gunnar F. 4
Accession 0001209191-22-004582
CIK 0001260990other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:00 PM ET
Size
5.7 KB
Accession
0001209191-22-004582
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2022-01-20+162,457→ 162,457 totalExercise: $1.94Exp: 2032-01-20→ Common Stock (162,457 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in 36 equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786754
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:00 PM ET
- Size
- 5.7 KB